Of those who received the 4CMenB vaccine at 2 , 4 , 6 , 12 and 40 months ( n = 16 ) , the percentage with protective antibody titres ( 1:4 ) at 60 months ranged from 44 % to 88 % against matched strains and from 13 % to 81 % against mismatched strains .